GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Cash And Cash Equivalents

Elixxer (Elixxer) Cash And Cash Equivalents : $0.08 Mil (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer Cash And Cash Equivalents?

Elixxer's quarterly cash and cash equivalents declined from Mar. 2023 ($0.25 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.08 Mil).

Elixxer's annual cash and cash equivalents declined from Dec. 2020 ($1.64 Mil) to Dec. 2021 ($0.24 Mil) and declined from Dec. 2021 ($0.24 Mil) to Dec. 2022 ($0.05 Mil).


Elixxer Cash And Cash Equivalents Historical Data

The historical data trend for Elixxer's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Cash And Cash Equivalents Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.64 5.04 1.64 0.24 0.05

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.05 0.25 - 0.08

Elixxer Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Elixxer  (OTCPK:ELIXF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Elixxer Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Elixxer's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (Elixxer) Business Description

Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (Elixxer) Headlines

From GuruFocus

Elixxer, Ltd. announces changes to the Board of Directors

By Marketwired Marketwired 07-24-2020

Elixxer Ltd. Announces Revised Debt Settlement Transactions

By Marketwired Marketwired 03-02-2021

Elixxer Ltd. Announces Revised Debt Settlement Transactions

By Marketwired Marketwired 08-22-2020

Elixxer Ltd. Provides Update on Proposed Private Placement

By GlobeNewswire GlobeNewswire 10-08-2020

Elixxer Ltd. Closes $4 Million Secured Loan

By GlobeNewswire GlobeNewswire 10-07-2020

Little Green Pharma Continues Record Breaking Sales Growth

By Marketwired Marketwired 05-28-2020